5′ CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC
- 31 March 2006
- journal article
- Published by Elsevier BV in Clinical Biochemistry
- Vol. 39 (3), 259-266
- https://doi.org/10.1016/j.clinbiochem.2006.01.014
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Serological markers of liver cancerBest Practice & Research Clinical Gastroenterology, 2005
- An integrated epigenetic and genetic approach to common human diseaseTrends in Genetics, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- Cancer epigeneticsOncogene, 2003
- Relevance of DNA methylation in the management of cancerThe Lancet Oncology, 2003
- Genome-wide analysis of epigenetics in cancer.Annals of the New York Academy of Sciences, 2003
- Epidemiology of hepatocellular carcinomaToxicology, 2002
- DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesisHuman Molecular Genetics, 2001
- The epidemiology and prevention of hepatocellular carcinomaSeminars in Oncology, 2001